Atlas Trials

Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer

Clinical trial NCT02896803 · UNKNOWN

Trial details

NCT number
NCT02896803
Sponsor
Instituto do Cancer do Estado de São Paulo
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Neoplasms
Start date
2016-08-01
Primary completion
2021-07-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.